View Older Stories View More Recent Stories

Aug 5, 2025 09:34AM Vertex (VRTX) PT Lowered to $530 at BMO Capital
Aug 5, 2025 09:28AM Vertex (VRTX) PT Lowered to $455 at Stifel
Aug 5, 2025 09:27AM Vertex (VRTX) PT Raised to $471 at Bernstein SocGen Group
Aug 5, 2025 09:04AM Vertex (VRTX) PT Lowered to $485 at Cantor Fitzgerald
Aug 5, 2025 07:41AM Vertex (VRTX) PT Lowered to $490 at Truist Securities
Aug 5, 2025 07:11AM Vertex (VRTX) PT Lowered to $478 at H.C. Wainwright
Aug 5, 2025 06:42AM Vertex (VRTX) PT Lowered to $458 at Leerink Partners
Aug 5, 2025 06:11AM Vertex (VRTX) PT Lowered to $553 at UBS
Aug 4, 2025 04:36PM After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more
Aug 4, 2025 04:03PM Vertex Pharma (VRTX) Tops Q2 EPS by 25c, Beats on Revenue; Offers FY25 Revenue Guidance
Aug 1, 2025 10:58AM Vertex Pharma (VRTX) call put ratio 1.4 calls to 1 put into quarter results
Aug 1, 2025 04:34AM Vertex Pharma (VRTX) call put ratio 1 call to 1.3 puts into quarter results
Jul 25, 2025 12:27PM Vertex (VRTX) PT Lowered to $38 at BMO Capital
Jul 22, 2025 01:01PM Vertex Pharma (VRTX) receives marketing authorization in Canada for Alyftrek
Jul 20, 2025 08:00PM U.S. large biotech stocks Q2 earnings preview
Jul 1, 2025 07:34AM Vertex Pharma (VRTX) Announces European Commission Approval of ALYFTREK
Jun 23, 2025 10:01AM William Blair Reiterates Outperform Rating on Vertex (VRTX)
Jun 23, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX)
Jun 17, 2025 10:14AM Vertex (VRTX) PT Lowered to $420 at RBC Capital
Jun 6, 2025 12:15PM Vertex Pharma (VRTX) reveals new data on ALYFTREK
Jun 6, 2025 09:56AM RBC Capital weighs in on Vertex (VRTX) following IgAN competitor data
Jun 5, 2025 12:44PM FDA Cell and Gene Therapy Roundtable 'bullish for the space' - Stifel
Jun 4, 2025 09:05AM Stifel on Sionna Therapeutics (SION): 'both compounds are able to attain exposures well above the modeled PK threshold'
Jun 3, 2025 07:53AM BofA Securities Reiterates Buy Rating on Vertex (VRTX)
May 30, 2025 12:46PM BMO Capital Reiterates Outperform Rating on Vertex (VRTX)
May 29, 2025 11:11AM UBS Reiterates Buy Rating on Vertex (VRTX) after positive doc call on Journavx uptake
May 23, 2025 05:47AM Erste Group Downgrades Vertex (VRTX) to Hold, 'The ratio of receivables to sales is also at a very high level'
May 21, 2025 12:49PM Scotiabank Reiterates Sector Perform Rating on Vertex (VRTX)
May 19, 2025 04:27PM Vertex Pharma (VRTX) Approves Additional $4B Buyback Program
May 14, 2025 09:29AM Stifel Reiterates Hold Rating on Vertex (VRTX)
May 7, 2025 07:23AM Bernstein on Vertex (VRTX): 'We'd Sit Tght' Following Yesterday's Stock Sell-Off
May 7, 2025 07:18AM H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX)
May 7, 2025 12:07AM Wolfe Research Downgrades Vertex (VRTX) to Peerperform
May 6, 2025 10:50AM Vertex (VRTX) PT Raised to $462 at Bernstein SocGen Group
May 6, 2025 09:59AM Stifel Reiterates Hold Rating on Vertex (VRTX)
May 6, 2025 09:11AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
May 6, 2025 07:08AM Vertex (VRTX) PT Lowered to $442 at Scotiabank
May 6, 2025 06:18AM Leerink Partners Downgrades Vertex (VRTX) to Market Perform 'on Lower Pain Projections'
May 5, 2025 04:45PM After-hours movers: Palantir, Ford, Clorox and more
May 5, 2025 04:04PM Vertex Pharma (VRTX) Misses Q1 EPS by 20c; raises guidance
May 5, 2025 05:33AM Vertex Pharma (VRTX) call put ratio 1.2 calls to 1 put into quarter results
May 2, 2025 11:07AM Vertex Pharma (VRTX) call put ratio 5.8 calls to 1 put into quarter results
Apr 22, 2025 10:56AM UBS Reiterates Buy Rating on Vertex (VRTX)
Apr 22, 2025 08:06AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
Apr 22, 2025 07:24AM Cantor Fitzgerald Assumes Vertex (VRTX) at Overweight
Apr 14, 2025 01:55PM BMO Capital on Vertex (VRTX): 'Growth Continues as We Look Ahead to 1Q Earnings'
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 7, 2025 12:01PM Vertex Pharma (VRTX) announces European Commission approval of KAFTRIO label expansion
Apr 1, 2025 08:24AM Vertex (VRTX) PT Raised to $420 at RBC Capital; 'Alyftrek Could Be Off To a Good Start'
Apr 1, 2025 06:40AM Canaccord Genuity Reiterates Hold Rating on Vertex (VRTX)
View More Recent Stories View Older Stories